Skip to main content

Table 1 Patient characteristics

From: Loss of MTUS1/ATIP expression is associated with adverse outcome in advanced bladder carcinomas: data from a retrospective study

 

aCGH bladder tumour cohort

Papillary bladder tumour cohort

Advanced bladder tumour cohort

Patients

n = 19

n = 85

n = 236

Age

Mean: 69.3 years

Mean: 70 years

Mean: 63 years

Median: 68 years

Median: 71 years

Median: 63.5 years

(± 9.9 years)

(± 11.6 years)

(± 8.4 years)

Range: 53 – 95 years

Range: 29–97 years

Range: 38–81 years

n.a. n = 4

Gender

Female: n = 5

Female: n = 22

Female: n = 56

Male: n = 14

Male: n = 63

Male: n = 177

n.a. n = 3

Stage

pTa n = 9

PUNLMP n = 1

pT1 n = 6

pT1 n = 10

pTa n = 47

pT2 n = 29

pT1 n = 31

pT3 n = 141

pT2 n = 4

pT4 n = 37

pT3 n = 1

n.a. n = 23

pT4 n = 1

Grade

lg n = 6

lg n = 40

G2, hg n = 28

hg n = 13

hg n = 42

G3, hg n = 203

n.a. = 3

n.a. n = 5

Follow-up OS

n.a.

Alive n = 65

Alive n = 76

Dead n = 15

Dead n = 129

n.a. n = 5

Follow-up DSS

n.a.

Alive n = 70

Alive n = 63

Dead n = 8

Dead n = 142

  

n.a. n =7

 
  1. Abbreviations: aCGH array based comparative genomic hybridization, OS overall survival, DSS disease-specific survival.